Eisler Capital (Us) LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Eisler Capital (Us) LLC
- $5.6 Trillion
- Q2 2024
A detailed history of Eisler Capital (Us) LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 32,054 shares of ARWR stock, worth $688,199. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,054Holding current value
$688,199% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$262 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$191 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$125 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$88.9 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.27B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...